I-HoME for Caregiver Burden

VP
Overseen ByVeerawat Phongtankuel, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a program called I-HoME, which uses video visits with a nurse practitioner to assist family caregivers in managing the care and symptoms of loved ones with advanced Alzheimer's Disease or related dementia. The goal is to determine if this approach is practical and helpful for caregivers. Participants should be English-speaking adults caring for someone with advanced dementia symptoms. As an unphased trial, this study offers caregivers a unique opportunity to explore innovative support methods.

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the I-HoME intervention is safe for family caregivers?

Research on the I-HoME intervention remains in the early stages, so specific safety data is not yet available. However, this intervention involves video calls with a nurse practitioner, which generally poses low risk. It focuses on managing symptoms and care needs through conversation and guidance. Since I-HoME is neither a drug nor a medical procedure, the risk of side effects is much lower compared to other treatments. Participants can expect a safe and supportive environment designed to help them manage caregiving challenges.12345

Why are researchers excited about this trial?

I-HoME is unique because it offers a personalized approach to managing caregiver burden through video visits with a nurse practitioner. Unlike traditional methods that often rely on in-person consultations, this treatment provides flexibility and convenience by allowing caregivers to receive support and guidance from home. Researchers are excited about this method because it could improve access to care, reduce stress for caregivers, and tailor interventions to specific needs, potentially leading to better outcomes for both caregivers and those they care for.

What evidence suggests that the I-HoME intervention is effective for reducing caregiver burden in advanced Alzheimer's Disease?

Initial findings suggest that the I-HoME program, which participants in this trial will receive, could help reduce stress for caregivers of patients with advanced Alzheimer's disease and related dementia. Research has shown that caregivers often experience anxiety and depression, with about 28.60% facing these mental health issues. I-HoME includes video calls with a nurse practitioner to help manage symptoms and care needs. By addressing these challenges, the program aims to reduce caregiver stress, potentially improving their mental health and quality of life.23467

Who Is on the Research Team?

VP

Veerawat Phongtankuel, MD

Principal Investigator

Weill Medical College of Cornell University

Are You a Good Fit for This Trial?

This trial is for family caregivers of patients with advanced Alzheimer's Disease and related dementias. It aims to support them in managing end-of-life issues using a technology-based intervention called I-HoME.

Inclusion Criteria

English speaking
I care for someone over 65 with advanced dementia, rated 7a-f on the FAST scale.

Exclusion Criteria

Non-English speaking
I am between 18 and 100 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs

12 weeks
6 visits (virtual)

Follow-up

Participants are monitored for changes in caregiver anxiety, burden, perception of patient's pain, and behavioral symptoms of dementia

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • I-HoME
Trial Overview The study is testing the I-HoME intervention, which uses technology to help caregivers manage end-of-life care challenges for dementia patients. The focus is on assessing how feasible and acceptable this approach is for participants.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Intervention (I-HoME)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Published Research Related to This Trial

This study analyzed caregiver burden using a large national sample of 409 caregivers, revealing that factors like the caregiver's gender, their relationship to the patient, and the patient's living situation significantly influence the level of burden experienced.
The research identified specific correlates of caregiver burden, with variance explained ranging from 25% for husbands living with patients to 68% for husbands with spouses in nursing homes, highlighting the need for tailored interventions based on caregiver circumstances.
Wives, husbands, and daughters caring for institutionalized and noninstitutionalized dementia patients: toward a model of caregiver burden.Harper, S., Lund, DA.[2017]
Family caregivers of people with dementia experience significant burdens, and transitioning care from home to nursing homes or outpatient group living does not fully alleviate these challenges, as shown in a study of 314 caregivers.
While some physical complaints improve with different care settings, the psychological burdens remain higher for home caregivers compared to those in nursing homes or outpatient care, indicating that issues persist regardless of the care environment.
[Caregiver's burden of caring for patients with dementia in group living compared to to domestic and inpatient care].Reggentin, H.[2019]
The In-Home pilot program, which involved 22 home care offices, enabled caregivers to report changes in care recipients' conditions after 2% of shifts, potentially helping to manage health issues at home and avoid hospitalizations.
Caregivers and care managers generally had positive attitudes towards the intervention, although challenges included staff resistance to change and the need for a flexible approach to meet diverse patient needs.
Preliminary Data on a Care Coordination Program for Home Care Recipients.Dean, KM., Hatfield, LA., Jena, AB., et al.[2018]

Citations

Exploring Factors Influencing Caregiver BurdenThis study aimed to systematically review and analyze factors contributing to caregiver burden among family caregivers of older adults with chronic illnesses ...
Prevalence of depression, anxiety, burden, burnout, and ...Specifically, caregiving has been linked to significantly higher rates of anxiety and depression, with one study in Canada reporting that approximately 28.60% ...
Caregiver Burden and Mental Health: Millennial CaregiversResearch has shown that caregivers of family members with mental illness have an increased incidence of depression, anxiety, and sleep disorders.
Stress as a Risk Factor for Informal Caregiver Burden - PMCThis study examined the connections between anxiety, depression, stress, and caregiver burden in informal caregivers.
The impact of caregiver burden on quality of life in family ...This study aims to probe the mediating effect of psychological distress on the relationship between caregiver burden and QoL, as well as the moderating effect ...
Changes in Health Indicators Among CaregiversThis report compares changes in the prevalence of 19 health indicators among caregivers and noncaregivers from 2015–2016 to 2021–2022.
Caregiver Burnout and Stress: 2023 Statistics and TrendsAs much as 60% of caregivers suffer from some level of emotional stress, which can lead to caregiver burnout, depression, and other health issues.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security